The Drugs Controller General of India has suspended the approval granted to Mumbai-based Entod Pharmaceuticals for manufacturing and sale of its eye drops— PresVu— for aggressively overselling the benefits of the product amid concerns of misuse by masses attempting to buy the prescription drug over-the-counter. “… considering the public interest, the permission dated 20.08.2024 issued to manufacture and market of …
